Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
  1. 425 Deal Prospectus/Communication re Business Combination
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. S-4/A Deal Registration Statement - Business Combination
  5. 425 Deal Prospectus/Communication re Business Combination
  6. 8-K Event Results of operations
  7. 425 Deal Prospectus/Communication re Business Combination
  8. 425 Deal Prospectus/Communication re Business Combination
  9. 8-K Event Material agreement
  10. 425 Deal Prospectus/Communication re Business Combination
  11. UPLOAD Other SEC-generated Letter
  12. 8-K Event Material agreement · Regulation FD disclosure
  13. S-4 Deal Registration Statement - Business Combination
  14. EFFECT Other Notice of Effectiveness
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. UPLOAD Other SEC-generated Letter
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. 8-K Event Regulation FD disclosure · Other events
  19. 425 Deal Prospectus/Communication re Business Combination
  20. 425 Deal Prospectus/Communication re Business Combination

Page 78 of 115 · 2,300 filings